510(k) K230852

HemosIL Chromogenic Factor IX by Instrumentation Laboratory Company — Product Code GGP

K230852 is an FDA 510(k) premarket notification submitted by Instrumentation Laboratory Company for the device "HemosIL Chromogenic Factor IX". The FDA issued a decision of Substantially Equivalent on December 13, 2023. The device falls under product code GGP (Test, Qualitative And Quantitative Factor Deficiency), a Class II device regulated under 21 CFR 864.7290. Instrumentation Laboratory Company has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 13, 2023
Date Received
March 28, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Test, Qualitative And Quantitative Factor Deficiency
Device Class
Class II
Regulation Number
864.7290
Review Panel
HE
Submission Type